Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs
Dorui pharmaceutical announced that ruidilian pharmaceutical, a holding subsidiary, signed a technology transfer contract with Henan University of traditional Chinese medicine, which agreed that Henan University of traditional Chinese medicine would transfer all patents and non patented technologies related to the clinical trial approval notice of "Yifei Jisheng Granule" and its new drug projects to ruidilian pharmaceutical.
This text is a result of machine translation.
Related companies：
In-depth
Yesterday 05:00 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Apr 18, 2022 06:30 PM
Automotive
NEV Maker Leapmotor Exposed to Rights Protection at Chongqing Auto Show
Leapmotor encountered rights protection at the 2022 Chongqing Auto Show on June 25. It was accused of presenting a black screen on the new car, promising to return the car while regretting the company’s response.
Updated 4 hours ago
See more
Read next
In-depth
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.